Soybean Bowman-Birk Protease Inhibitor (BBI): Identification of the Mechanisms of BBI Suppressive Effect on Growth of Two Adenocarcinoma Cell Lines: AGS and HT29
Authors:
- 1 August 2014
- journal article
- research article
- Published by Elsevier in Archives of Medical Research
- Vol. 45 (6) , 455-461
Abstract
No abstract availableKeywords
Funding Information
- The Research Fund of Medical Biology Research Center
This publication has 21 references indexed in Scilit:
- Hypoxia control to normalize pathologic angiogenesis: Potential role for endothelial precursor cells and miRNAs regulationVascular Pharmacology, 2012
- Accessories to the Crime: Functions of Cells Recruited to the Tumor MicroenvironmentCancer Cell, 2012
- Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: One step forward for overcoming anti‐angiogenic drug resistance?Molecular Oncology, 2011
- DNA methylation profiling in cancerExpert Reviews in Molecular Medicine, 2010
- Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesionSeminars in Cancer Biology, 2010
- Tumor angiogenesis – A potential target in cancer chemopreventionFood and Chemical Toxicology, 2008
- Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007Molecular Oncology, 2008
- Making the cut: Protease-mediated regulation of angiogenesisExperimental Cell Research, 2006
- Vascular endothelial growth factor (VEGF) and its receptorsThe FASEB Journal, 1999
- Chemopreventive AgentsPharmacology & Therapeutics, 1998